ISIS-3: fewer strokes with streptokinase.
D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D013927:Thrombosis / Q000188:drug therapy* / Q000401:mortality
D005343:Fibrinolytic Agents